Hypercholesterolemia: Clinical Trials

7 trials for Hypercholesterolemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Terminated 7
Phase 21Terminated 1

Follow Hypercholesterolemia: new trials by email Literature Review of Hypercholesterolemia trials Research Report on Hypercholesterolemia

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase
Cohort 1: bococizumab 150 mg + rHuPH20, Cohort 2: bococizumab 300 mg, Cohort 3: bococizumab 300 mg + rHuPH20 - Healthy, Hypercholesterolemia
Phase 1TerminatedPfizer602016-02-012016-10-21
Single Dose Study of PF-06815345 in Healthy Subjects
PF-06815345, Placebo - Hypercholesterolemia
Phase 1TerminatedPfizer252015-11-012018-09-28
A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia
BMS-852927, Placebo - Hypercholesterolemia
Phase 1TerminatedBristol-Myers Squibb972012-11-012013-08-05
Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH
SPC5001, Saline 0.9% - Hypercholesterolemia
Phase 1TerminatedSantaris Pharma A/S242011-05-012011-11-22
Safety Study of BMS-844421 for Treatment of Hypercholesterolemia
BMS-844421, 0.9% sodium chloride injection solution - Atherosclerosis, Hypercholesterolemia
Phase 1TerminatedBristol-Myers Squibb402010-04-012011-01-26
Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol
PRO-040201, Placebo - Hypercholesterolemia
Phase 1TerminatedArbutus Biopharma Corporation232009-06-012010-01-22
Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
3,5-Diiodothyropropionic acid (DITPA) therapy - Hypercholesterolemia
Phase 1 / Phase 2TerminatedJohns Hopkins University602006-04-012013-04-02

Narrower conditions

Hyperlipidemias (2)  ·  Atherosclerosis (1)  ·  Coronary Artery Disease (1)  ·  Dyslipidemias (1)

Broader conditions

Lipid Metabolism Disorders (7)  ·  Metabolic Diseases (7)  ·  Nutritional and Metabolic Diseases (7)  ·  Dyslipidemias (6)  ·  Hyperlipidemias (5)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)

Interventions

3,5-diiodothyropropionic acid (1)  ·  SPC5001 (1)  ·  Sodium Chloride (1)  ·  Therapeutics (1)

Sponsors

Bristol-Myers Squibb (2)  ·  Pfizer (2)  ·  Arbutus Biopharma Corporation (1)  ·  Johns Hopkins University (1)  ·  Santaris Pharma A/S (1)

Countries

Belgium (2)  ·  Germany (2)  ·  United States (2)  ·  Canada (1)  ·  Netherlands (1)

Top investigators

Annabelle Rodriguez, MD (1)  ·  Douglas Logan, MD (1)  ·  Koos Burggraaf, MD PhD (1)

Results publications

PMID 26261033, PMID 30623096

NIH funding

2015 (2), 2009 (1)